Pyrroles
=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C | 100mg | 335409657](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000130170.jpg-250.jpg)
eMolecules 341031-54-7 | Sunitinib Malate | Target Molecule | MFCD08282795 | 532.569 | C26H33FN4O7 | 0.000 | O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C | 100mg | 335409657
Sunitinib Malate | Target Molecule | 341031-54-7 | MFCD08282795 | 532.569 | C26H33FN4O7 | 0.000 | O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C | 100mg | 335409657
Medchemexpress LLC Pizotifen malate | 5189-11-7 | 99.0% | C23H27NO5S | 100 MG
Pizotifen malate (Pizotyline malate) is a potent 5-HT2 receptor antagonist with high affinity for the 5-HT1C binding site. It acts as an antidepressant 5-HT2A receptor antagonist, capable of inhibiting serotonin-enhanced ADP-induced platelet aggregation. This product is intended for research use only and is not sold to patients.
- Potent 5-HT2 receptor antagonist
- High affinity for the 5-HT1C binding site
- Antidepressant 5-HT2A receptor antagonist
- Inhibits serotonin-enhanced ADP-induced platelet aggregation
- Intended for research use only
Cayman Chemical 4-hydroxy Atorvastatin calci
A metabolite of atorvastatin; formed by metabolism of atorvastatin by CYP3A4
Medchemexpress LLC Atorvastatin ethyl ester | 1146977-93-6 | MFCD28143549 | 98.2% | 586.69 g/mol | C35H39FN2O5 | 5 MG
Atorvastatin ethyl ester is a research chemical derivative of atorvastatin reported to strongly inhibit 9-cis-retinoic acid (9-cis-RA)-induced Gal4 reporter activity. It is intended for preclinical research use and is characterized by CAS 1146977-93-6, molecular formula C35H39FN2O5, and molecular weight 586.69 g/mol.
- Reported inhibitor of 9-cis-RA-induced Gal4 reporter activity.
- Intended for research use only, not for human consumption.
- High purity (98.2%).
- Characterized by CAS 1146977-93-6 and formula C35H39FN2O5.
- Available in small pack sizes suitable for assay development, including five mg packs.
Medchemexpress LLC Atorvastatin lactone | 125995-03-1 | MFCD00899262 | 96.7% | 540.62 g·mol-1 | C33H33FN2O4 | 5 MG
Atorvastatin lactone is the lactone (prodrug) form of atorvastatin, acting as an HMG-CoA reductase inhibitor used in research on cholesterol biosynthesis, statin metabolism, and enzymatic assays. Supplied as a purified solid, it is typically prepared as a DMSO stock for in vitro and analytical applications.
- Prodrug/lactone form of atorvastatin for metabolic and pharmacology studies.
- High purity suitable for analytical and biochemical assays.
- Powder form; soluble in DMSO for stock preparations.
- Molecular weight approximately 540.62 g·mol-1.
- Used as an HMG-CoA reductase inhibitor in research applications.
Medchemexpress LLC 4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-methoxybenzamide;2-hydroxybutanedioic acid | 57645-91-7 | MFCD01743960 | 99.4% | 507.96 | C24H30ClN3O7 | 10 MG
Clebopride malate is the malate salt of clebopride, an orally active dopamine D2 receptor antagonist supplied as a research-grade analytical standard for laboratory pharmacology and analytical studies. It is provided as a high-purity solid intended for controlled experimental use and should be stored sealed and away from moisture; solutions may be frozen for extended storage.
- Malate salt form of clebopride.
- Orally active dopamine D2 receptor antagonist.
- High purity suitable for analytical applications.
- Supplied in a small research-grade pack for laboratory use.
- Stable when stored sealed and away from moisture; follow refrigerated or frozen conditions for solutions.
AdipoGen Sunitinib . malate (5 mg)
Chemical. CAS: 341031-54-7. Formula: C22H27FN4O2 . C4H6O5. MW: 398.5 . 134.1. Potent ATP-competitive and cell permeable multi-targeted receptor tyrosine kinase (RTK) inhibitor targeting VEGFR and PDGFR-beta. Inhibits FLK1 (Ki=9nM), PDGFRbeta (Ki=8nM) and FLT3. It is at least 10-fold selective for FLK1 and PDGFRbeta over a variety of tyrosine kinases in a panel, including EGFR, Cdk2, Met, IGFR-1, Abl and Src. Inhibits the cellular receptor phosphorylation of FLT3, RET and CSF-1R. Also shown to inhibit c-Kit. Exhibits potent antiangiogenic and antitumor activity in multiple xenograft models.
Medchemexpress LLC Atorvastatin epoxy tetrahydrofuran impurity | 873950-19-7 | 449.47 | 100 MG
Atorvastatin epoxy tetrahydrofuran impurity is an oxidative degradation product of atorvastatin. Atorvastatin is an orally active HMG-CoA reductase inhibitor known for effectively decreasing blood lipids. This product is intended for research use only.
- Impurity of atorvastatin
- Isolated oxidative degradation product
- For research use only
Medchemexpress LLC HY-10820 100mg Medchemexpress, Pemetrexed LY231514 CAS:137281-23-3 Purity:98%
Medchemexpress,HY-10820 100mg Pemetrexed LY231514 CAS:137281-23-3 Formula:C20H21N5O6 Pemetrexed is a novel antifolate, the Ki values of the pentaglutamate of LY231514 are 1.3, 7.2, and 65 nM for inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively. Purity:98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Apexbio Technology LLC Pizotifen Malate 5189-11-7 300mg
Pizotifen malate (CAS 5189-11-7) is a benzocycloheptane derivative that functions as a potent antagonist of serotonin (5-HT) receptors exhibiting high selectivity for this target class By inhibiting serotonergic neurotransmission Pizotifen malate is utilized in biomedical research to investigate the physiological and pharmacological roles of 5-HT pathways Its receptor blocking properties enable studies focused on serotonergic modulation migraine mechanisms and disorders associated with altered serotonin signaling
Apexbio Technology LLC atorvastatin(Synonyms: Lipitor, Atorvastatin calcium, Sortis, Torvast, Atorva, Tahor, Zarator, Atorlip, Lipvas, Ator, Tulip), 500mg, CAS: 134523-00-5.
Atorvastatin (CAS 134523-00-5) is an orally bioavailable inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase the enzyme catalyzing the rate-limiting step of cholesterol biosynthesis via the mevalonate pathway Beyond its cholesterol-lowering activity atorvastatin can modulate cardiovascular processes independently of lipid reduction primarily through inhibiting small GTPases such as Ras and Rho known contributors to cardiovascular pathology and vascular dysfunction Additionally atorvastatin has demonstrated inhibition of abdominal aortic aneurysm development by interfering with endoplasmic reticulum stress signaling pathways This molecule is frequently used in biomedical studies involving cholesterol metabolism vascular cell biology and cardiovascular disease research